coronary heart disease
Conditions
Interventions
experimental group:real acupuncture+conventional treatment
control group:sham acupuncture+conventional treatment
Sponsors
Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
21 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Male or female, aged =21 years and =85 years. (2) Coronary angiography results indicating evidence of single-vessel or multi-vessel coronary artery disease. (3) Presence of angina symptoms prior to the current PCI. (4) Successful PCI as per the operator's plan, with PCI success defined as complete or partial angiographic success, without in-hospital death, Q-wave myocardial infarction, or urgent revascularization, and the indication for PCI being any of the following angina-related conditions: 1) chronic coronary syndrome; 2) unstable angina or non-ST-elevation myocardial infarction (NSTEMI). (5) Implantation of at least one drug-eluting stent. (6) Patients who voluntarily participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Individuals who have undergone acupuncture treatment for cardiovascular diseases or participated in other clinical trials within 3 months prior to enrollment. (2) Individuals who are unable to comply with the study procedures or follow-up visits. (3) Individuals for whom more than 24 hours have elapsed between the completion of the PCI procedure and enrollment. (4) Individuals with an expected survival of less than 1 year. (5) Individuals scheduled for further revascularization procedures (PCI or CABG) during the study period. (6) Individuals who underwent PCI in the absence of prior angina, including those with asymptomatic ischemia. (7) Individuals with procedure-related Q-wave myocardial infarction or acute myocardial injury due to the procedure. (8) Individuals who, after successful PCI, experience one or more of the following: acute myocardial infarction, including acute or subacute in-stent thrombosis. (9) Individuals with known laboratory abnormalities. (10) Individuals with known concurrent serious conditions. (11) Pregnant or breastfeeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| seattle angina questionnaire,SAQ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Canadian Cardiovascular Society Classification,CCSC;visual analogue score,VAS;Self-Rating Anxiety Scale,SAS;Self-Rating Depression Scale,SDS;Pittsburgh Sleep Quality Index,PSQI;the MOS 36-item Short Form Health Survey,SF-36; | — |
Countries
China
Contacts
Public ContactRen yulan
Chengdu University of Traditional Chinese Medicine
Outcome results
None listed